NanJing Pharmaceutical Company Limited (600713.SS) SHH

5.18

-0.01(-0.19%)

Updated at December 05 11:29AM

Currency In CNY

Valuation

Market Cap6.46B
Enterprise Value9.4B
P/E Ratio12.55
PEG Ratio-2.7
Price/Sales Ratio0.13
Price/Book Ratio0.96
Enterprise/Revenue0.3
Enterprise/EBITDA13.3

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.01
Operating Margin0.02

Management Effectiveness

Return On Assets0.02
Return On Equity0.08

Income Statement

Revenue53.7B
Revenue/Share41.9
Gross Profit3.37B
EBITDA1.67B
Net Income570.63M
Diluted EPS0.44

Balance Sheet

Total Cash1.98B
Total Cash/Share1.54
Total Debt10.93B
Total Debt/Equity1.57
Current Ratio1.45
Book Value Per Share6.18

Price History

52-Week Change0.39
52-Week High5.64
52-Week Low4.55
Moving Average 50 Days5.06
Moving Average 200 Days5.09

Statistics

Average Volume13.3M
Shares Outstanding1.31B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.17
Trailing Annual Dividend Yield3.28
Payout Ratio0.78
Last Split Factor2:1
Last Split DateJuly 08, 2011